15 search results for: caregiver burden

The Weight of Breath: The Impact of Pediatric Asthma on Patients and <b>Caregiver</b>s
Pulmonology
The Weight of Breath: The Impact of Pediatric Asthma on Patients and Caregivers
videoanimation

Learn about the multifaceted burden of uncontrolled pediatric asthma on patients and their caregivers.

View more
ADVENT at EADV 2026
On Demand
Stepping Up: Expert Perspectives on CSU From Diagnosis to Disease Control

Drs Martin Metz, Moshe Ben-Shoshan, and Michelle Tarbox shared expert perspectives on chronic spontaneous urticaria (CSU) during an engaging ADVENT symposium at EADV 2026 in Vienna, Austria. The symposium explored key considerations across the CSU patient journey, from diagnosis to disease control. Key topics included the multifaceted burden of CSU on patients, caregivers, and families, practical approaches to diagnosis and assessment of disease control, and considerations for treatment escalation and advanced therapy selection in adult and pediatric patients with CSU.

Stepping Up: Expert Perspectives on CSU From Diagnosis to Disease Control
Dermatology
Stepping Up: Expert Perspectives on CSU From Diagnosis to Disease Control
expert video

Join Drs. Martin Metz, Moshe Ben-Shoshan, and Michelle Tarbox as they share expert insights on the burden of pediatric CSU, as well as key considerations for disease diagnosis and treatment escalation in pediatric and adult patients.

View more
ADVENT at NAPNAP 2025
Congress
12
March
2025
Congress
ADVENT at NAPNAP 2025

Join experts Jonathan Spergel, MD, PhD, Wanda Phipatanakul, MD, MS, and Jerry Ellen Schonfeld, CPNP, at an educational symposium as they investigate the role of type 2 inflammation in pediatric diseases. The speakers will also discuss the difficulties in diagnosis and burdens patients and their families face.

ADVENT at EADV 2026
On Demand
Atopic Dermatitis at ​an Inflection Point: ​Refining Outcomes Through Timely, Targeted Intervention

Prof. Tilo Biedermann and Drs. Nicole Chase and Lisa Swanson presented an engaging ADVENT educational symposium at EADV 2026 on September 30 in Vienna, Austria, focusing on the local and systemic role of type 2 inflammation in atopic dermatitis (AD) and its implications for disease management across the lifespan. The symposium explored the potential to achieve sustained optimal disease control with systemic therapy in adults, as well as the potential window of opportunity for early intervention to reduce or prevent multidimensional disease burden in pediatric AD.

ADVENT in Orlando, FL 2025
Congress
7
March
2025
Congress
ADVENT in Orlando, 2025

Type 2 inflammation contributes to many dermatologic diseases, which may lead to potentially life-changing burdens and challenges to patients and caregivers. By uncovering the role of type 2 inflammation in the pathophysiology of AD, PN, CSU, and BP, we can move forward in our understanding of each disease. Join global experts for an educational symposium on March 8th that will uncover the role of type 2 inflammation in the pathophysiology of AD, PN, CSU, and BP and explore questions driving current research in each disease.

EoE Quest: Navigating the Patient Experience
Gastroenterology
EoE Quest: Navigating the Patient Experience
interactivity

Want to test your EoE knowledge while learning more about the patient journey? Try EoE Quest, an engaging and educational interactive experience.

View more
Complex EoE Pathophysiology Beyond Esophageal Eosinophilia
Gastroenterology
Complex EoE Pathophysiology Beyond Esophageal Eosinophilia
expert video

Dr. Jonathan Spergel and Prof. Arjan Bredenoord highlight the importance of different immune cells in type 2 inflammation in EoE.

View more
ADVENT at EADV 2026
Congress
29
September
2026
Congress
ADVENT at EADV 2026

Please join the ADVENT program at EADV 2026 for educational sessions on AD, PN, and CSU! Experience 3 high-impact sessions led by world-renowned experts, bridging scientific innovation with real-world clinical outcomes.

.
Congress
9
March
2024
Congress
The Benefits of Early Intervention in AD: More Than Skin Deep

Many AD treatment goals focus on clinical manifestations, so that if a patient is free of lesions, their disease is considered well controlled. However, the inflammatory process underlying AD reaches far beyond the skin, affecting patients in unique ways at different stages of their lives. Education on the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient will help improve clinical management and reduce long-term patient burden.